This site is intended for healthcare professionals
Optimising anti-TNF treatment using biosimilars Learning Zone

Expert Opinion

Last updated:11th Oct 2022
Published:29th Oct 2020

Explore independently-led content from leading experts on the use of anti-tumour necrosis factor (αTNF) biosimilars to treat three conditions:

  • Watch videos on the role of αTNF biosimilars in rheumatoid arthritis and common misconceptions about biosimilars in rheumatology
  • Learn about the burden of hidradenitis suppurativa on patients
  • Consider strategies for treating inflammatory bowel disease with αTNF biosimilars

Factors that influence the initiation of biologic treatments

Find out the factors that influence the initiation of biologic treatments, such as early diagnosis with laboratory diagnostics using rheumatoid factor and anti-citrullinated protein antibodies, early referral, and the early initiation of disease-modifying antirheumatic drugs (DMARD) treatment.

Access to biologic treatment options

Learn how the arrival of tumour necrosis factor alpha inhibitor (anti-TNF) biosimilars has affected access to biologic treatment options, the initiation of treatment, and how various countries, including South Korea, Australia and European nations, have expanded their use of anti-TNF biosimilars.

Treatment cycling and switching

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

The burden of hidradenitis suppurativa


Hidradenitis suppurativa imposes a burden on the life of the patient. From the difficulties of treating patients to the psychological impact it can have day to day, find out how this disease adversely effects quality of life.

Unmet needs in hidradenitis suppurativa


There has been an explosion of research in the last few years on hidradenitis suppurativa. Gain a deeper understanding of the unmet needs of this previously poorly understood disease, including a vicious circle of inadequate treatment and the difficulties of accessing care.

Treatment options for hidradenitis suppurativa

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

The impact of inflammatory bowel disease


Inflammatory bowel disease is a long-term condition that significantly impacts the lives of patients. Learn about the symptoms of the disease and the extraintestinal manifestations of symptoms. See how treatment and surgery affects patients.

Timely initiation of biologic treatments


Getting the right treatment to the right patient at the right time is essential. Find out the importance of risk stratification, access to effective treatments, effective multidisciplinary work, and patient communication.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Professor Thomas Dörner

Introducing Professor Thomas Dörner, a board-certified Rheumatologist and Professor of Rheumatology and Haemostaseology at Charité University Hospital, Berlin, Germany.

Professor Joao Goncalves

Meet Professor Joao Goncalves, Director of the iMed-Research Institute for Medicines, and Professor of Immunology and Pharmacology at the University of Lisbon, Portugal.

Dr Joana Cabete


Introducing Dr Joana Cabete, a dermatology and venereology consultant at Santo António dos Capuchos Hospital, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.

Professor Tiago Torres

Meet Professor Tiago Torres, Department of Dermatology and Dermatology Research Unit, Centro Hospitalar do Porto, University of Porto, Portugal.

Dr Nick Kennedy


Introducing Dr Nick Kennedy, a Consultant Gastroenterologist at the Royal Devon and Exeter NHS Foundation Trust and Honorary Clinical Senior Lecturer at the University of Exeter Medical School, Exeter, UK.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: